|
Depreciation and amortization
|
|
$23.9m
|
$27.7m
|
$37.3m
|
$44.8m
|
$47.5m
|
$45.8m
|
$52.8m
|
$50.9m
|
|
Deferred income taxes
|
|
($5.0m)
|
($3.1m)
|
$851k
|
$1.7m
|
$2.2m
|
($980k)
|
$4.3m
|
$9.9m
|
|
Change in operating leases
|
|
—
|
—
|
—
|
($7.9m)
|
($8.9m)
|
($10.5m)
|
($12.0m)
|
($11.8m)
|
|
Net loss
|
|
($16.5m)
|
($23.6m)
|
($57.9m)
|
($25.3m)
|
($31.8m)
|
($30.9m)
|
($62.3m)
|
($843k)
|
|
Provision (recovery) for credit loss
|
|
—
|
—
|
—
|
—
|
—
|
$3.1m
|
($146k)
|
$6.7m
|
|
Non-cash leases expense
|
|
—
|
—
|
—
|
—
|
—
|
$10.2m
|
$11.6m
|
$11.8m
|
|
Stock-based compensation expense
|
|
$5.8m
|
$4.3m
|
$4.8m
|
$10.3m
|
$43.3m
|
$47.3m
|
$64.7m
|
$42.7m
|
|
Fair value changes in financial instruments
|
|
($352k)
|
$7.1m
|
$11.0m
|
$2.2m
|
($3.4m)
|
($4.1m)
|
$3.1m
|
($18.3m)
|
|
Write off of deferred financing costs
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
$913k
|
|
Other operating activities, net
|
|
—
|
—
|
—
|
—
|
($4.0m)
|
$3.1m
|
$608k
|
$668k
|
|
Accounts receivable and contract assets
|
|
($10.0m)
|
($6.6m)
|
($19.2m)
|
($36.2m)
|
$4.4m
|
($2.9m)
|
($42.0m)
|
($10.1m)
|
|
Prepaid expenses and other current assets
|
|
($101k)
|
($2.5m)
|
($956k)
|
($886k)
|
($1.8m)
|
($918k)
|
($552k)
|
($3.3m)
|
|
Accounts payable and other accrued liabilities
|
|
($2.2m)
|
$6.1m
|
$601k
|
$24.0m
|
($9.9m)
|
($8.9m)
|
$3.8m
|
$8.3m
|
|
Accrued payroll and benefits
|
|
$449k
|
$2.2m
|
$6.1m
|
$3.2m
|
($6.8m)
|
$9.5m
|
($1.7m)
|
$18.5m
|
|
Payment of contingent consideration
|
|
—
|
—
|
($6.4m)
|
($15.6m)
|
($19.5m)
|
($611k)
|
—
|
—
|
|
Other assets
|
|
—
|
($1.6m)
|
($3.2m)
|
($262k)
|
—
|
—
|
$378k
|
$1.3m
|
|
Proceeds from corporate owned and property insurance
|
|
—
|
—
|
$0
|
$413k
|
$329k
|
$573k
|
$224k
|
—
|
|
Purchases of property and equipment
|
|
($3.8m)
|
($4.7m)
|
($7.2m)
|
($6.9m)
|
($10.0m)
|
($29.6m)
|
($21.3m)
|
($16.3m)
|
|
Proceeds from the sale of property and equipment
|
|
$166k
|
$260k
|
$20k
|
$597k
|
$174k
|
$971k
|
$2.1m
|
$712k
|
|
Proprietary software development and other software costs
|
|
($337k)
|
($21k)
|
($570k)
|
($699k)
|
($593k)
|
($3.4m)
|
($2.5m)
|
($695k)
|
|
Purchase price true ups
|
|
—
|
—
|
$1.9m
|
($9.3m)
|
($389k)
|
($1.4m)
|
($3.3m)
|
$458k
|
|
Minority investments
|
|
—
|
—
|
—
|
—
|
—
|
($2.6m)
|
($210k)
|
—
|
|
Cash paid for acquisitions, net of cash acquired
|
|
($45.8m)
|
($81.4m)
|
($173.9m)
|
($55.7m)
|
($28.6m)
|
($66.2m)
|
($113.1m)
|
—
|
|
Proceeds from revolving line of credit
|
|
$109.4m
|
$146.3m
|
$104.4m
|
$109.0m
|
—
|
—
|
$403.1m
|
$477.6m
|
|
Repayment of the revolving line of credit
|
|
($89.4m)
|
($68.7m)
|
($202.0m)
|
($109.0m)
|
—
|
—
|
($377.6m)
|
($419.8m)
|
|
Proceeds from the aircraft loan
|
|
—
|
—
|
—
|
—
|
—
|
$10.9m
|
—
|
—
|
|
Repayment of aircraft loan
|
|
—
|
—
|
—
|
—
|
—
|
($591k)
|
($1.1m)
|
($1.1m)
|
|
Proceeds from term loan
|
|
$35.3m
|
—
|
$175.0m
|
$175.0m
|
—
|
—
|
$50.0m
|
$200.0m
|
|
Repayment of term loan
|
|
($71.6m)
|
($1.2m)
|
($49.8m)
|
($173.9m)
|
($8.8m)
|
($12.2m)
|
($15.0m)
|
($191.7m)
|
|
Payment of contingent consideration and other purchase price true ups
|
|
($2.0m)
|
($1.1m)
|
($6.0m)
|
($9.9m)
|
($11.1m)
|
($1.9m)
|
($363k)
|
($11.0m)
|
|
Repayment of finance leases
|
|
—
|
($2.0m)
|
($2.8m)
|
($2.7m)
|
($4.0m)
|
($4.6m)
|
($5.5m)
|
($11.1m)
|
|
Payments of deferred financing costs
|
|
—
|
—
|
($4.2m)
|
($446k)
|
($183k)
|
—
|
($348k)
|
($2.4m)
|
|
Proceeds from building sale leaseback
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
$2.5m
|
|
Redemption of series A-2 Preferred Stock
|
|
—
|
—
|
—
|
—
|
—
|
—
|
($60.0m)
|
($122.2m)
|
|
Foreign exchange impact on cash balance
|
|
—
|
($116k)
|
($15k)
|
($183k)
|
($111k)
|
($876k)
|
($497k)
|
($224k)
|
|
Beginning of year
|
|
$2.5m
|
$6.9m
|
$34.9m
|
$146.7m
|
$89.8m
|
$23.2m
|
$12.9m
|
$11.2m
|
|
Property and equipment purchased under finance leases
|
|
$3.1m
|
$4.3m
|
$2.1m
|
$1.8m
|
$5.1m
|
$8.3m
|
$9.4m
|
$23.4m
|
|
Acquisitions unpaid contingent consideration
|
|
$4.8m
|
$5.4m
|
$54.5m
|
$35.8m
|
$8.3m
|
$6.0m
|
$33.1m
|
$17.6m
|
|
Acquisitions contingent consideration paid in common stock
|
|
—
|
—
|
—
|
$26.1m
|
—
|
$1.0m
|
$1.1m
|
$7.3m
|
|
Non-cash considerations received from sale of subsidiary
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
$4.5m
|
|
Accrued purchases of property and equipment
|
|
$793k
|
$975k
|
$432k
|
$790k
|
$2.3m
|
$1.1m
|
$983k
|
$1.2m
|
|
Accrued lease surrender liability
|
|
—
|
—
|
—
|
—
|
—
|
$5.9m
|
—
|
—
|
|
Promissory note receivable issued in connection with the sale of assets of the Discontinued Specialty Lab
|
|
—
|
—
|
—
|
—
|
—
|
$4.3m
|
—
|
—
|
|
Net cash provided by operating activities
|
|
($2.8m)
|
$17.0m
|
$1.9m
|
$37.6m
|
$20.6m
|
$56.0m
|
$22.2m
|
$107.5m
|
|
Common stock issued to acquire new businesses
|
|
$5.6m
|
$4.0m
|
$25.0m
|
$8.3m
|
—
|
$2.6m
|
$10.7m
|
—
|
|
Net cash used in investing activities
|
|
($50.3m)
|
($87.0m)
|
($179.7m)
|
($71.6m)
|
($38.7m)
|
($101.6m)
|
($138.0m)
|
($15.8m)
|
|
Proceeds from issuance of common stock for exercised stock options
|
|
—
|
$1.5m
|
$408k
|
$7.2m
|
$1.6m
|
$4.7m
|
$2.1m
|
$1.1m
|
|
Proceeds from issuance of common stock in follow-on offering, net of issuance costs
|
|
$30k
|
$1.5m
|
$408k
|
—
|
—
|
—
|
$121.8m
|
—
|
|
Dividend payment to the series A-2 stockholders
|
|
—
|
—
|
($7.0m)
|
($16.4m)
|
($16.4m)
|
($16.4m)
|
($11.1m)
|
($4.2m)
|
|
Net cash provided by (used in) financing activities
|
|
$50.9m
|
$74.5m
|
$205.9m
|
$146.1m
|
($38.8m)
|
($20.1m)
|
$106.0m
|
($93.1m)
|
|
Change in cash, cash equivalents and restricted cash
|
|
($2.3m)
|
$4.5m
|
$28.0m
|
$112.0m
|
($56.8m)
|
($65.7m)
|
($9.8m)
|
($1.5m)
|
|
Cash paid for interest
|
|
$7.9m
|
$5.9m
|
$11.9m
|
$5.0m
|
$6.5m
|
$8.1m
|
$14.8m
|
$17.9m
|
|
Taxes paid related to net share settlement of equity awards
|
|
$596k
|
$1.2m
|
$171k
|
$412k
|
$789k
|
$997k
|
$4.2m
|
($10.7m)
|
|
Cash paid for income tax
|
|
$596k
|
$1.2m
|
$171k
|
$412k
|
$789k
|
$997k
|
$4.2m
|
$5.5m
|